Ogivri, a Biosimilar to Herceptin, Now Available in the US
A biosimilar is a biological product that is approved based on data demonstrating high similarity to an FDA-approved biological product (reference product).
Diana Ernst, RPh
Editorial Director
Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.
